Literature DB >> 23076707

Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis.

Per Zetterström1, Karin S Graffmo, Peter M Andersen, Thomas Brännström, Stefan L Marklund.   

Abstract

A common cause of amyotrophic lateral sclerosis is mutations in superoxide dismutase-1, which provoke the disease by an unknown mechanism. We have previously found that soluble hydrophobic misfolded mutant human superoxide dismutase-1 species are enriched in the vulnerable spinal cords of transgenic model mice. The levels were broadly inversely correlated with life spans, suggesting involvement in the pathogenesis. Here, we used methods based on antihuman superoxide dismutase-1 peptide antibodies specific for misfolded species to explore the composition and amounts of soluble misfolded human superoxide dismutase-1 in tissue extracts. Mice expressing 5 different human superoxide dismutase-1 variants with widely variable structural characteristics were examined. The levels were generally higher in spinal cords than in other tissues. The major portion of misfolded superoxide dismutase-1 was shown to be monomers lacking the C57-C146 disulfide bond with large hydrodynamic volume, indicating a severely disordered structure. The remainder of the misfolded protein appeared to be non-covalently associated in 130- and 250-kDa complexes. The malleable monomers should be prone to aggregate and associate with other cellular components, and should be easily translocated between compartments. They may be the primary cause of toxicity in superoxide dismutase-1-induced amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076707     DOI: 10.1007/s12017-012-8204-z

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  42 in total

1.  Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models.

Authors:  Daniel Bergemalm; P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Anna Rehnmark; Stefan L Marklund
Journal:  J Neurosci       Date:  2006-04-19       Impact factor: 6.167

2.  Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.

Authors:  Per Zetterström; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Stefan L Marklund
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

3.  Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1.

Authors:  P Andreas Jonsson; Karin S Graffmo; Thomas Brännström; Peter Nilsson; Peter M Andersen; Stefan L Marklund
Journal:  J Neuropathol Exp Neurol       Date:  2006-12       Impact factor: 3.685

4.  Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.

Authors:  Adrian Israelson; Nir Arbel; Sandrine Da Cruz; Hristelina Ilieva; Koji Yamanaka; Varda Shoshan-Barmatz; Don W Cleveland
Journal:  Neuron       Date:  2010-08-26       Impact factor: 17.173

5.  Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation.

Authors:  Yoshiaki Furukawa; Thomas V O'Halloran
Journal:  J Biol Chem       Date:  2005-02-03       Impact factor: 5.157

6.  Denaturational stress induces formation of zinc-deficient monomers of Cu,Zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis.

Authors:  Vikram Khipple Mulligan; Aaron Kerman; Sylvia Ho; Avijit Chakrabartty
Journal:  J Mol Biol       Date:  2008-08-22       Impact factor: 5.469

7.  Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase.

Authors:  Can Kayatekin; Jill A Zitzewitz; C Robert Matthews
Journal:  J Mol Biol       Date:  2008-09-26       Impact factor: 5.469

8.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

9.  Initiation and elongation in fibrillation of ALS-linked superoxide dismutase.

Authors:  Madhuri Chattopadhyay; Armando Durazo; Se Hui Sohn; Cynthia D Strong; Edith B Gralla; Julian P Whitelegge; Joan Selverstone Valentine
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-20       Impact factor: 11.205

Review 10.  Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.

Authors:  Hristelina Ilieva; Magdalini Polymenidou; Don W Cleveland
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

View more
  16 in total

1.  Misfolded SOD1 is not a primary component of sporadic ALS.

Authors:  Sandrine Da Cruz; Anh Bui; Shahram Saberi; Sandra K Lee; Jennifer Stauffer; Melissa McAlonis-Downes; Derek Schulte; Donald P Pizzo; Philippe A Parone; Don W Cleveland; John Ravits
Journal:  Acta Neuropathol       Date:  2017-02-28       Impact factor: 17.088

2.  Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy.

Authors:  Ashok Sekhar; Jessica A O Rumfeldt; Helen R Broom; Colleen M Doyle; Ryan E Sobering; Elizabeth M Meiering; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

3.  Thermal fluctuations of immature SOD1 lead to separate folding and misfolding pathways.

Authors:  Ashok Sekhar; Jessica A O Rumfeldt; Helen R Broom; Colleen M Doyle; Guillaume Bouvignies; Elizabeth M Meiering; Lewis E Kay
Journal:  Elife       Date:  2015-06-23       Impact factor: 8.140

4.  Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping.

Authors:  Johan Bergh; Per Zetterström; Peter M Andersen; Thomas Brännström; Karin S Graffmo; P Andreas Jonsson; Lisa Lang; Jens Danielsson; Mikael Oliveberg; Stefan L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

5.  Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.

Authors:  Adrian Israelson; Dara Ditsworth; Shuying Sun; SungWon Song; Jason Liang; Marian Hruska-Plochan; Melissa McAlonis-Downes; Salah Abu-Hamad; Guy Zoltsman; Tom Shani; Marcus Maldonado; Anh Bui; Michael Navarro; Huilin Zhou; Martin Marsala; Brian K Kaspar; Sandrine Da Cruz; Don W Cleveland
Journal:  Neuron       Date:  2015-03-19       Impact factor: 17.173

6.  Effects of maturation on the conformational free-energy landscape of SOD1.

Authors:  Robert M Culik; Ashok Sekhar; Jayashree Nagesh; Harmeen Deol; Jessica A O Rumfeldt; Elizabeth M Meiering; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

7.  Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice.

Authors:  Guilian Xu; Jacob I Ayers; Brittany L Roberts; Hilda Brown; Susan Fromholt; Cameron Green; David R Borchelt
Journal:  Hum Mol Genet       Date:  2014-10-09       Impact factor: 6.150

Review 8.  Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis.

Authors:  Piia Vehviläinen; Jari Koistinaho; Goldsteins Gundars
Journal:  Front Cell Neurosci       Date:  2014-05-09       Impact factor: 5.505

9.  Analysis of mutant SOD1 electrophoretic mobility by Blue Native gel electrophoresis; evidence for soluble multimeric assemblies.

Authors:  Hilda H Brown; David R Borchelt
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

10.  Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients.

Authors:  Isil Keskin; Elin Forsgren; Dale J Lange; Markus Weber; Anna Birve; Matthis Synofzik; Jonathan D Gilthorpe; Peter M Andersen; Stefan L Marklund
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.